Company Overview and News

 
Subway builder eyes ferries

2018-08-26 bworldonline
TO EASE traffic congestion in the country’s main financial center, there’s no way to go but underground and afloat, said businessman Antonio L. Tiu, who is leading a venture for one of two subway projects in the capital region.
IRC

 
Work on Makati subway to start in December –Binay

2018-08-23 newsinfo.inquirer.net
The construction of the $3.7-billion intra-city subway project in Makati City will begin in December 2018. /PHOTO: Courtesy of Ed Lustan
IRC

 
Construction of Makati City subway system to start in December

2018-08-23 newsinfo.inquirer.net
The construction of the $3.7-billion intra-city subway project in Makati City will begin in December 2018. /PHOTO: Courtesy of Ed Lustan
IRC

 
Makati mass transport system to break ground by ‘year end’

2018-08-23 bworldonline
The $3.7-billion unsolicited proposal to build a Makati Mass Transport system is seen to break ground by the end of the year, the Makati City government said.
IRC

 
Makati mass transport bid to face Swiss challenge

2018-07-25 bworldonline
IRC Properties, Inc. said its proposed $3.7-billion Makati Mass Transport system will now undergo Swiss challenge after securing approval from the Makati city government.
IRC

 
$3.7-B subway project ready for Swiss challenge

2018-07-24 business.inquirer.net
A $3.7-billion Makati subway system proposed by IRC Properties Inc. under a joint venture with the Makati city government will be up for a Swiss challenge or price competition soon.
IRC PSKXF PHSXY PSE

 
IRC Properties to proceed with Swiss challenge for Makati transport project

2018-07-24 bworldonline
IRC Properties, Inc. said it will now proceed with the Swiss challenge for its proposed $3.7-billion Makati Mass Transport system, after securing approval from the Makati City government and other regulators.
IRC

8
Capital raised via stock market hits P150 billion in first half

2018-07-01 bworldonline
CAPITAL raised at the stock market reached a record P150 billion in the first half, as companies braved the local market amid prevailing volatility.
IRC PSKXF CHIB SUAFF RBLAY BSC DD CKGOY RLC PHSXY PSE FNI BCDTY

 
IRC to implement structural changes ahead of Makati subway construction

2018-06-21 bworldonline
IRC Properties, Inc. is making key structural changes to its company in preparation for the construction of its proposed subway system in Makati.
IRC

 
IRC-led group gets original proponent status for Makati subway project

2018-06-20 business.inquirer.net
A consortium led by property developer IRC Properties has bagged “original proponent status” from the Makati City government for an unsolicited proposal to build a $3.7-billion subway system to ease traffic bottlenecks within the city, which is home to the country’s premier central business district.
IRC

 
IRC gets original proponent status for Makati mass transport system

2018-06-20 bworldonline
IRC Properties, Inc. secured original proponent status from the Makati government for its proposed $3.7-billion intra-city rail transport system.
IRC

 
IRC proposes mass transport system in Makati

2018-06-04 bworldonline
IRC Properties, Inc., now led by businessman Antonio L. Tiu, is seeking to build a mass transportation system within Makati City to address traffic congestion in the country’s central business district.
IRC

1
IRC Properties doubles capital base

2018-04-12 bworldonline - 1
In a disclosure to the stock exchange on Thursday, the property developer said its board of directors approved the increase in authorized capital stock to P3 billion from P1.5 billion.
IRC

Related Articles

ALIM: Alimera Sciences Analysis and Research Report

2018-10-01 - Asif

Overview The following discussion and analysis should be read in conjunction with its unaudited interim condensed consolidated financial statements and the related notes that appear elsewhere in this quarterly report on Form 10-Q. This discussion contains forward-looking statements reflecting its current expectations that involve risks and uncertainties. Actual results may differ materially from those discussed in these forward-looking statements due to a number of factors, including those set forth in the section entitled “Risk Factors” in its most recent annual report on Form 10-K. For further information regarding forward-looking statements, please refer to the “Special Note Regarding Forward-Looking Statements and Projections” immediately after the index to this quarterly report on Form 10-Q. Alimera Sciences, Inc., and its subsidiaries (we or Alimera), is a pharmaceutical company that specializes in the commercialization and development of prescription ophthalmic pharma...

DMPI: DelMar Pharmaceuticals Analysis and Research Report

2018-09-25 - Asif

Background DelMar Pharmaceuticals, Inc. is a clinical stage drug development company with a focus on the treatment of cancer. The company's mission is to benefit patients and create shareholder value by developing and commercializing anti-cancer therapies for patients whose tumors exhibit features that make them resistant to, or unlikely to respond to, currently available therapies, particularly for orphan cancer indications where patients have failed, or are unlikely to respond to, currently available therapy. DelMar Pharmaceuticals is developing VAL-083, a novel, DNA-targeting agent, for the treatment of glioblastoma multiforme (“GBM”) and potentially other solid tumors, including ovarian cancer. VAL-083 is a first-in-class, DNA-targeting chemotherapeutic that demonstrated activity against a range of tumor types in prior Phase 1 and Phase 2 clinical studies sponsored by the US National Cancer Institute (“NCI”). The company's recent research has highlighted the opportunit...

RIGL: Rigel Pharmaceuticals Analysis and Research Report

2018-09-18 - Asif

Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...

Silicon Investor Message Boards

This table lists all message boards related to PSE:IRC / IRC Properties, Inc. on message board site Silicon Investor.

Aircraft leasing companies. FLY, AER, WLFC Aircraft leasing companies. FLY, AER, WLFC Aircraft leasing companies. FLY, AER, WLFC Trader Ju0027s Inner Circle Trader Ju0027s Inner Circle Trader Ju0027s Inner Circle
CENTRAL Rand Gold ( CRND ) Bidders Circling CENTRAL Rand Gold ( CRND ) Bidders Circling CENTRAL Rand Gold ( CRND ) Bidders Circling ADI: The SHARCs are circling! ADI: The SHARCs are circling! ADI: The SHARCs are circling!
CarMax (KMX) - a recent IPO of a Circuit City unit CarMax (KMX) - a recent IPO of a Circuit City unit CarMax (KMX) - a recent IPO of a Circuit City unit Jabil Circuit (JBL) Jabil Circuit (JBL) Jabil Circuit (JBL)
Circuit City (CC) Circuit City (CC) Circuit City (CC) Circa Pictures u0026 Production Company International Circa Pictures u0026 Production Company International Circa Pictures u0026 Production Company International
The ZONE Circle of Friends The ZONE Circle of Friends The ZONE Circle of Friends Birch Mountain Resources BMD-ASE Birch Mountain Resources BMD-ASE Birch Mountain Resources BMD-ASE